​​

In the Yousefpour lab, we develop next-generation biomolecular immunotherapies by integrating approaches from protein engineering, synthetic biology, and biomaterial science to address treatment challenges across various indications, including cancer and infectious diseases. We focus on engineering RNA- and protein-based platforms to finely modulate immune responses, enhancing therapeutic efficacy while minimizing adverse effects.

​